Facebook Twitter LinkedIn Google Plus RSS

Parsippany-based Zoetis to acquire Abaxis for $2B

By ,

Zoetis Inc. a pharmaceutical company for animals based in Parsippany, has announced its intent to acquire Abaxis Inc., which makes veterinary instruments, for $2 billion.

Under the terms of the agreement, Zoetis will pay $83 per share to California-based Abaxis’ shareholders.

“We see a prime opportunity to grow our business as part of Zoetis,” said Clint Severson, Abaxis’ chairman and CEO, in a statement. “We recently invested in expanding operations in Europe, Latin America and the Asia Pacific region, with 20 percent of revenue in fiscal year 2018 coming from our international operations. Zoetis has the global presence and direct veterinary customer relationships to deliver greater value to more customers around the world and accelerate the growth of our international operations.”

The transaction is expected to close by year’s end.

You May Have Missed...

Vince Calio

Vince Calio

Vince Calio covers health care and manufacturing for NJBIZ. You can contact him at vcalio@njbiz.com.

Leave a Comment


Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy